Navigation Links
Tianyin Pharmaceutical to Hold 2010 Shareholder Annual Meeting on March 21, 2011 at NYSE
Date:1/7/2011

CHENGDU, China, Jan. 7, 2011  /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced that the Company's 2010 Annual Meeting of Stockholders will be held at New York Stock Exchange Conference Room 632 on Monday, March 21, 2011, at 10:00 am (EST).

Tianyin's Board of Directors has established Friday, February 4, 2011, as the record date for determining stockholders entitled to vote at the Annual Meeting.

Stockholder proposals must be received no later than Tuesday, February 8, 2011, in order to be considered for inclusion in the Company's proxy statement or to be presented at the Annual Meeting. Stockholder proposals should be mailed to Tianyin Pharmaceutical, c/o Leser, Hunter, Taubman & Taubman, 17 State Street, Floor 20, New York, New York 10004.

About Tianyin Pharmaceuticals

Tianyin Pharmaceutical Co., Inc., headquartered at Chengdu, China, is a pharmaceutical company that specializes in the development, manufacturing, marketing and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicines, branded generics and other pharmaceuticals. Tianyin currently manufactures a comprehensive portfolio of 56 products, of which 23 are listed in the national medicine reimbursement list, 7 are included in the essential drug list of China. Tianyin currently has a pipeline of 10 late stage products pending the SFDA approval that target various high incidence healthcare indications. Tianyin has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about Tianyin, please visit:  h
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tianyin Pharmaceutical, Co. Announces Cash Dividend to Common Shareholders - Record Date October 30, 2009
2. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
3. Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
4. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products
5. Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association
6. Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET
7. Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
8. Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6
9. Tianyin Corporate Presentation Updated
10. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2010 Earnings Conference Call on Thursday, September 30, 2010 at 9:00 a.m. ET
11. Tianyin Pharmaceutical Co., Inc. to Host First Quarter of Fiscal Year 2011 Earnings Conference Call on Thursday, November 11, 2010 at 9:00 a.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... New York , July 29, 2015 ... by Transparency Market Research " Active Pharmaceutical Ingredients (API) ... and Forecast 2014 - 2020 " the global active ... in 2013 and is anticipated to reach USD 185.9 ... during the forecast period from 2014 to 2020. ...
(Date:7/29/2015)... , July 24, 2015 Research ... addition of the "Global Wound Care Markets ... United States, Japan, Canada, China, India, Brazil, Australia, ... The report provides a competitive market ... terms of both product offerings and product maturity. ...
(Date:7/29/2015)... YORK , July 29, 2015 /PRNewswire/ ... a new research report "Global Industry Insight: ... to 2020" with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... http://photos.prnewswire.com/prnh/20150727/756778 ) Microfluidic devices  ...
Breaking Medicine Technology:Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5Global Wound Care Markets 2015 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5
... PARK, Calif., March 22, 2011 Telome Health, Inc. ... property portfolio. THI will provide telomere length data from ... health monitoring. THI leverages the predictive ... protective caps at the ends of chromosomes, to assess ...
... MOUNT PROSPECT, Ill., March 22, 2011 The National Association ... the prescription monitoring programs (PMPs) of North Dakota , ... agreements to participate in the PMP Interconnect ™ system, ... United States to be linked, providing a more effective means ...
Cached Medicine Technology:Telome Health, Inc. Launches With Exclusive IP Portfolio 2Telome Health, Inc. Launches With Exclusive IP Portfolio 3Three States Sign on to Participate in NABP's Interconnected Prescription Monitoring System 2Three States Sign on to Participate in NABP's Interconnected Prescription Monitoring System 3
(Date:7/29/2015)... Aliso Viejo, CA (PRWEB) , ... July 29, 2015 , ... ... rotating wipe animations. Designed as drag & drop presets for FCPX, these transitions are ... direction controls, which add versatility to each transition. With over 60 preset styles, kinetic ...
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native Douglas James ... Dr. Cottrell has been making predictions about the economy, politics, social issues, as ... these prognostications. He warns that extreme weather conditions and increased earthquake / volcanic ...
(Date:7/29/2015)... ... , ... The Woodlands and Spring Fit Body Boot Camps have implemented an ... each month. The new system will track each time a client uses social media ... facility, the boot camps will donate 20 cents to a selected charity. , Fit ...
(Date:7/29/2015)... ... 2015 , ... People that are passionate about gardening and those that have ... “garden tower” and enhanced mineral product for growing ideal crops. , The ... balcony, or rooftop – can hold up to 100 plants in just 4 square ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth Callahan, ... Sarasota to be chosen by the manufacturer to offer and perform Kybella™ ... non-invasive way to treat and eliminate double chin fat,” Dr. Callahan explained. “Previously ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3
... Enrollment under way for individual sessions or 14-week ... 12 The Center for Autism and Related ... a new 14-part educational series for parents of ... Disorder (ASD). This includes children with Asperger,s Disorder, ...
... supplements that long, research shows , , TUESDAY, May 12 (HealthDay ... conception, folic acid supplements can help reduce the chance of ... Texas researchers say. , Their study, published in the May ... to a reduction in the odds of giving birth before ...
... May 11, 2009 Dental implants are frequently used ... restore the patient,s tooth function and appearance. Previous research ... the host tissue in the area of the implant, ... maintain the patient,s bone and gum tissue surrounding the ...
... against bird and seasonal flu viruses , ... at the Dana-Farber Cancer Institute and the Centers ... of human monoclonal antibodies that neutralize an unprecedented ... A (H5N1) virus, previous pandemic influenza viruses and ...
... - Marketed as Align(R) ... Alimentary Health Ltd. ("Alimentary Health" or "the ... its,licensing partner Procter & Gamble (P&G), that Align, ... against episodic digestive,upsets, is now available nationwide in ...
... to those needing to work from home or ... Ericom Software, a global leader in Application ... remote access solution, PowerTerm WebConnect can significantly reduce ... loss during disaster situations, such as an H1N1 ...
Cached Medicine News:Health News:Education Series Offered For Parents Of Children Diagnosed With An Autism Spectrum Disorder 2Health News:Placement of dental implants results in minimal bone loss 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 3Health News:Recent developments at Burnham Institute for Medical Research, May 2009 4Health News:Recent developments at Burnham Institute for Medical Research, May 2009 5Health News:Alimentary Health's Probiotic Technology Launched Nationwide in the US 2Health News:Alimentary Health's Probiotic Technology Launched Nationwide in the US 3Health News:Alimentary Health's Probiotic Technology Launched Nationwide in the US 4Health News:Ericom's Remote Access and Business Continuity Solution Increases Immunity to Productivity Losses -- Combats Swine Flu Scare 2Health News:Ericom's Remote Access and Business Continuity Solution Increases Immunity to Productivity Losses -- Combats Swine Flu Scare 3
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...
... a prescription eye drop that your ... after your cataract surgery. Cataract surgery ... them to become inflamed. The key ... redness and swelling. If left untreated, ...
ALOCRIL® ophthalmic solution is a prescription eye drop for itchy allergy eyes. ALOCRIL® provides control beyond relief by providing continuous symptom control throughout the allergy season....
... ophthalmic solution is a prescription eye ... you to use after your cataract ... and may cause them to become ... of inflammation include redness and swelling. ...
Medicine Products: